Skye Bioscience, Inc. (SKYE) News
Follow Skye Bioscience, Inc. (SKYE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Key facts: Skye Bioscience, Inc. $68M PIPE; Board additions and CMO
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.
NEWS | Sep 30, 2026, 07:02 AM UTC
L
Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing
Skye Bioscience, Inc. NASDAQ:SKYE
REGULATION | Sep 11, 2026, 08:33 PM UTC
L
Skye Bioscience CFO John P. Sharp resigns; Punit Dhillon named principal financial officer
Skye Bioscience appointed Punit Dhillon as principal financial and accounting officer effective September 8, 2026, following the resignation of Chief Financial Officer John P. Sharp.Original SEC Filing: Skye Bioscience,
REGULATION | Sep 11, 2026, 08:24 PM UTC
L
Skye Bioscience Ends Master Services Agreement With Lohman & Associates After CFO Resignation
Skye Bioscience terminated its Master Services Agreement with Lohman & Associates, effective Sep 8, 2026, following the resignation of CFO John P. Sharp. The termination occurred the same day notice was given and represe
NEWS | Sep 11, 2026, 08:24 PM UTC
L
Redx Pharma closes Series A funding round
Redx Pharma Limited closed a Series A round and strengthened board composition.
EQUITY | Aug 27, 2026, 08:30 AM UTC
M
Several stocks begin reverse splits Monday Aug. 24
BIAF, BRCC, INCR, VCIG, GRML, GAME and SKYE are listed for reverse stock splits on Monday Aug. 24, with ratios ranging from 1-for-5 to 1-for-50.
EQUITY | Aug 24, 2026, 09:05 AM UTC
M
Multiple stocks set reverse splits for Monday Aug. 24
BIAF, BRCC, INCR, VCIG, GRML, GAME and SKYE are listed for reverse stock splits effective Monday Aug. 24, with ratios ranging from 1-for-5 to 1-for-50.
EQUITY | Aug 23, 2026, 11:52 AM UTC
M
Skye Bioscience and Redx Pharma agree transaction; raise $125m
Skye Bioscience and Redx Pharma announce a transaction agreement and financings totaling $125 million.
MNA | Aug 14, 2026, 01:33 PM UTC